December 5, 2016

ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that George A. Komatsoulis, Ph.D., will be its first Chief of Bio-Informatics. This marks another step toward the organization's goal of making the CancerLinQ® platform the premier system for unlocking patient data from millions of electronic health records (EHR), breaking down silos among various EHR systems and providers, and securely processing and analyzing the data to give personalized insights than can improve the quality of care for patients with cancer.

November 30, 2016

Alexandria, Va. – CancerLinQ LLC, a nonprofit subsidiary of the American Society of Clinical Oncology® (ASCO), today announced CancerLinQ Discovery™, a groundbreaking offering that will provide insights through the analysis of real-world cancer care data. CancerLinQ Discovery will provide highly curated, de-identified sets of clinical data with the objective of creating new clinical knowledge and improving patient outcomes. It will derive these sets from the rapidly-growing CancerLinQ® database, which now includes over 1.5 million patient records and more than 70 oncology practices that have agreed to contribute data to CancerLinQ’s core quality improvement and data-sharing platform.

November 30, 2016

“Today, by passing the 21st Century Cures Act, the U.S. House of Representatives took a significant step forward to accelerate the pace of bringing promising new treatments to patients—including the 1.6 million Americans diagnosed with cancer each year. The American Society of Clinical Oncology (ASCO) commends the passage of the Cures Act by the House and urges the U.S. Senate to support and send this landmark legislation to the President for his signature.”

November 29, 2016

Alexandria, Va. – The American Society of Clinical Oncology (ASCO) today released, "Criteria for High-Quality Clinical Pathways in Oncology," a set of 15 inter-related criteria that provide an overarching framework for assessing pathway programs in the United States. ASCO developed the criteria to guide stakeholders in assessing the quality, utility and integrity of clinical pathways in oncology.

November 23, 2016

The American Society of Clinical Oncology (ASCO) will honor Anna T. Meadows, MD, a distinguished pediatric oncologist who led the way for survivorship studies of children with cancer, with its inaugural Ellen L. Stovall Award and Lecture for Advancement of Cancer Survivorship Care.

November 16, 2016

ALEXANDRIA, Va. – More than 100 participants are now enrolled on study drug in the American Society of Clinical Oncology’s (ASCO®) Targeted Agent and Profiling Utilization Registry (TAPUR) Study. The trial launched in March 2016 at 37 sites and this month welcomes its newest participating clinical sites: Cancer Treatment Centers of America®, Intermountain Healthcare, Sanford Health, Swedish Cancer Institute and Providence Health & Services, and University of Nebraska Medical Center for a total of 63 participating sites in 15 states.

November 15, 2016

ALEXANDRIA, VA – A new collaboration between the American Society of Clinical Oncology (ASCO) and the American Board of Internal Medicine (ABIM) will enable participants of ASCO’s Quality Oncology Practice Initiative (QOPI®) and the QOPI Certification Program (QCP) to receive Maintenance of Certification (MOC) Practice Assessment points from ABIM.

November 1, 2016

Alexandria, Va. – The American Society of Clinical Oncology (ASCO) and Innovative Oncology Business Solutions, Inc., (IOBS) today announced a new collaboration, ASCO COME HOME, an oncology medical home program designed to transition community oncology practices from volume-based to value-based care by structuring reimbursement around the full range of services needed by patients with cancer.

October 31, 2016

A new study suggests that a widely available web-based program (InsightTM) can help cancer survivors reporting cognitive symptoms. The 15-week program markedly improved participants’ self-reported (perceived) cognitive function, lowered anxiety and depression, and improved fatigue. The findings were published online today in the Journal of Clinical Oncology.

October 24, 2016

“ASCO is concerned by the number of cancer deaths that continue to be caused by cigarette smoking in the United States, as revealed in the American Cancer Society’s study on state-level cancer mortality attributed to cigarette smoking. This research shows that approximately one-third of cancer deaths in men and one-quarter in women were associated with cigarette smoking.  Of particular concern is the high proportion of cigarette-related cancer deaths in southern states.

October 20, 2016

ALEXANDRIA, Va. – CancerLinQ LLC, a wholly-owned nonprofit of the American Society of Clinical Oncology (ASCO), announced today that more than one million patient records are now in the CancerLinQ™ platform. In addition, 70 practices have signed agreements to participate in CancerLinQ, representing more than 1,500 oncologists.

October 17, 2016

Vice President Biden and the government-wide Cancer Moonshot Task Force have presented today a sweeping vision that, if realized, could change the face of cancer prevention, screening, treatment, and survivorship—as we know it.

October 14, 2016

“The American Society of Clinical Oncology (ASCO) applauds the Centers for Medicare & Medicaid Services (CMS) for taking a critical step toward transitioning Medicare from volume-based reimbursement to a system that emphasizes high-quality, patient-centered care. In today’s release of the MACRA Quality Payment Program (QPP), CMS has demonstrated welcomed flexibility and choices for clinicians. 

October 12, 2016

ALEXANDRIA, VA. – The American Society of Clinical Oncology (ASCO) today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide.

October 10, 2016

ALEXANDRIA, Va. – CancerLinQ LLC (CLQ LLC) CEO Kevin Fitzpatrick has been appointed to the Cancer Informatics for Cancer Centers (CI4CC) Corporate Advisory Board. CancerLinQ LLC is a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology, Inc. (ASCO®) and Mr. Fitzpatrick’s appointment builds on CI4CC and CLQ LLC’s collaborative efforts to help improve cancer care.